US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Real RE/MAX Group (NASDAQ:REAX) Q3 Revenue Beats Estimates While EPS Shortfall Pressures Shares
↗
November 05, 2026
Via
Chartmill
Tickers
REAX
Papa John's Intl Inc (NASDAQ:PZZA) Shares Fall on Q3 Revenue and EPS Miss, Softened 2026 Outlook
↗
November 05, 2026
Via
Chartmill
Tickers
PZZA
PALVELLA THERAPEUTICS INC (NASDAQ:PVLA) Narrows Q3 Loss Ahead of February 2027 PDUFA Decision
↗
November 05, 2026
Via
Chartmill
Tickers
PVLA
Priority Technology Holdings (NASDAQ:PRTH) Q3 Beat Overshadowed by Pending $8.05 Take-Private Deal
↗
November 05, 2026
Via
Chartmill
Tickers
PRTH
PENN Entertainment (NASDAQ:PENN) Earnings Beat and Narrowing Interactive Losses Drive Shares Higher
↗
November 05, 2026
Via
Chartmill
Topics
Earnings
Tickers
PENN
Exposures
Financial
Payoneer Global (NASDAQ:PAYO) Q3 Results Miss Estimates as Nuvei Merger Approval Drives Premarket Surge
↗
November 05, 2026
Via
Chartmill
Tickers
PAYO
Nova Ltd (NASDAQ:NVMI) Q3 2026 Results In Line as Shares Slip Premarket
↗
November 05, 2026
Via
Chartmill
Tickers
NVMI
N-able (NYSE:NABL) Q3 2026 Earnings: EPS Beat, Revenue In Line, Q4 Guidance Below Consensus
↗
November 05, 2026
Via
Chartmill
Tickers
NABL
MACOM Technology Solutions (NASDAQ:MTSI) Posts In-Line Revenue, Strong Margins, and Above-Consensus Guidance as Shares Slip
↗
November 05, 2026
Via
Chartmill
Tickers
MTSI
Middleby Corp (NASDAQ:MIDD) Q3 Adjusted EPS Beat and Raised Outlook Drive Shares Higher
↗
November 05, 2026
Via
Chartmill
Tickers
MIDD
McGraw Hill (NYSE:MH) Posts Mixed Q2 as EPS Beats Estimates but Revenue Misses on K-12 Softness
↗
November 05, 2026
Via
Chartmill
Tickers
MH
Madison Air Solutions (NYSE:MAIR) Q3 Earnings Beat Faces Muted Premarket Reaction
↗
November 05, 2026
Via
Chartmill
Topics
Earnings
Tickers
MAIR
Exposures
Financial
Lexicon Pharmaceuticals (NASDAQ:LXRX) Q3 2026 Beat Rests on Novo Milestone as SONATA-HCM and ZYNQUISTA Catalysts Loom
↗
November 05, 2026
Via
Chartmill
Tickers
LXRX
Analog Devices (NASDAQ:ADI): A Dividend Quality Candidate for Income Investors
↗
November 05, 2026
Via
Chartmill
Tickers
ADI
Lucky Strike Entertainment (NYSE:LUCK) Q1 FY2027 Results: Inline Revenue, Wider Loss, and Debt-Reduction Focus
↗
November 05, 2026
Via
Chartmill
Tickers
LUCK
Kimbell Royalty Partners LP (NYSE:KRP) Q3 Revenue and EPS Miss Despite Record Production
↗
November 05, 2026
Via
Chartmill
Tickers
KRP
IMAX Corp (NYSE:IMAX) Posts Q3 2026 Earnings Beat as Record Box Office Drives 64% Revenue Growth
↗
November 05, 2026
Via
Chartmill
Topics
Earnings
Tickers
IMAX
Exposures
Financial
Installed Building Products (NYSE:IBP) Slides as Margin Pressure Offsets In-Line Revenue
↗
November 05, 2026
Via
Chartmill
Tickers
IBP
Global Payments (NYSE:GPN) Q3 2026 Results In Line, Reaffirms Outlook
↗
November 05, 2026
Via
Chartmill
Tickers
GPN
Frontdoor Inc (NASDAQ:FTDR) Q3 Results In Line as Guidance Lands Slightly Below Consensus
↗
November 05, 2026
Via
Chartmill
Tickers
FTDR
MSA Safety (NYSE:MSA) Emerges as a Quality-Investing Candidate
↗
November 05, 2026
Via
Chartmill
Tickers
MSA
Shift4 Payments (NYSE:FOUR) Slides as Q3 Revenue Miss Overshadows EPS Beat
↗
November 05, 2026
Via
Chartmill
Tickers
FOUR
Evolent Health (NYSE:EVH) Q3 2026 Earnings: In-Line Revenue, EPS Beat, but Premarket Shares Slide
↗
November 05, 2026
Via
Chartmill
Tickers
EVH
Distribution Solutions Group (NASDAQ:DSGR) Q3 Beat Overshadowed by Pending Take-Private Deal
↗
November 05, 2026
Via
Chartmill
Tickers
DSGR
1stDibs (NASDAQ:DIBS) Slides as Soft Holiday Outlook Weighs on In-Line Q3 Results
↗
November 05, 2026
Via
Chartmill
Tickers
DIBS
Ceragon Networks (NASDAQ:CRNT) Q3 EPS Beat and Margin Gains Spark Premarket Rally
↗
November 05, 2026
Via
Chartmill
Tickers
CRNT
Cannabis Stocks Are Splitting Into Profitable Leaders and Sentiment-Driven Laggards
↗
November 05, 2026
Via
Chartmill
Topics
Cannabis
Tickers
ACB
CGC
CRON
IIPR
JAZZ
Exposures
Cannabis
S&P 500 Premarket Movers for Nov. 5: Gainers and Losers
↗
November 05, 2026
Via
Chartmill
Topics
Stocks
Tickers
AMCR
APP
BE
CHTR
CTSH
DELL
Exposures
US Equities
Core Scientific (NASDAQ:CORZ) Q3 2026 Results Beat Estimates as Colocation Revenue Surges
↗
November 05, 2026
Via
Chartmill
Tickers
CORZ
Collegium Pharmaceutical (NASDAQ:COLL) Posts Mixed Q3 as EPS Beats, Revenue Misses, and Guidance Holds
↗
November 05, 2026
Via
Chartmill
Tickers
COLL
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >